Dr. Paolo F. Caimi
Claim this profileCase Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute
Area of expertise
Non-Hodgkin's Lymphoma
Paolo F. Caimi has run 4 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Lymphoma
Paolo F. Caimi has run 3 trials for Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute
Cleveland Clinic Foundation
Clinical Trials Paolo F. Caimi is currently running
BAFF CAR-T
for Non-Hodgkin Lymphoma
This trial is testing a new immune cell therapy for patients with non-Hodgkin lymphoma who haven't responded to other treatments. The therapy involves modifying the patient's own immune cells to better recognize and attack their cancer.
Recruiting
1 award
Phase 1
BAFF CAR-T Cells
for Chronic Lymphocytic Leukemia
CAR-T cell treatment of refractory lymphoma has shown success, particularly with CD-19 targeted CAR-T cells, however, many participants are refractory or relapse after response. Responses are more limited in CLL/SLL, possibly secondary to the suppressive effect of circulating B cells on T cell function. BAFF receptor is a target that has been explored in CLL. Preclinical data indicates that CAR- T cells expressing B-cell activating factor (BAFF) can be another effective strategy to treat refractory CLL. This study aims to explore the efficacy of LMY-920 a BAFF-ligand CAR T cells with depletion of B cells with Obinutuzumab prior to apheresis.
Recruiting
1 award
Phase 1
7 criteria
More about Paolo F. Caimi
Clinical Trial Related
6 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Paolo F. Caimi has experience with
- Brentuximab Vedotin
- Cytarabine
- Bendamustine
- Acalabrutinib
- Rituximab
- UF-KURE19 CAR-T Cells
Breakdown of trials Paolo F. Caimi has run
Non-Hodgkin's Lymphoma
Lymphoma
T-Cell Lymphoma
B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paolo F. Caimi specialize in?
Paolo F. Caimi focuses on Non-Hodgkin's Lymphoma and Lymphoma. In particular, much of their work with Non-Hodgkin's Lymphoma has involved Stage IV patients, or patients who are CD19 positive.
Is Paolo F. Caimi currently recruiting for clinical trials?
Yes, Paolo F. Caimi is currently recruiting for 2 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Paolo F. Caimi has studied deeply?
Yes, Paolo F. Caimi has studied treatments such as Brentuximab Vedotin, Cytarabine, Bendamustine.
What is the best way to schedule an appointment with Paolo F. Caimi?
Apply for one of the trials that Paolo F. Caimi is conducting.
What is the office address of Paolo F. Caimi?
The office of Paolo F. Caimi is located at: Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland, Ohio 44195 United States. This is the address for their practice at the Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.